Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.

International journal of biological macromolecules - 1 Nov 2015

Wang Yuchan, Wu Yaxun, Miao Xiaobing, Zhu Xinghua, Miao Xianjing, He Yunhua, Zhong Fei, Ding Linlin, Liu Jing, Tang Jie, Huang Yuejiao, Xu Xiaohong, He Song

Abstract excerpt

DYRK2, a dual-specificity tyrosine-(Y)-phosphorylation regulated kinase gene, is involved in regulating many processes such as cell proliferation, cell differentiation and cytokinesis. DYRK2 also plays an important role in many cancers, such as breast cancer, non-small cell lung cancer and esophageal adenocarcinomas. In this study, we found that DYRK2 is associated with the proliferation of Non-Hodgkin's lymphoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion
Share to Cyclin-Dependent Kinase Inhibitor p27

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyrk Kinases

Share to Gene Knockdown Techniques

Share to Gene Silencing

Share to Lymphoma, Large B-Cell, Diffuse

Share to Lymphoma, Non-Hodgkin

Share to Protein-Tyrosine Kinases

Source

Identifiers

PMID: 26341817
DOI: 10.1016/j.ijbiomac.2015.08.067

Genes

DYRK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.PMID 26341817Read ↗

Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer CellsSemantic proximity Read ↗

The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic OpportunitiesSemantic proximity Read ↗

Engagement of DYRK2 in proper control for cell division.Semantic proximity Read ↗

Multiple functions of DYRK2 in cancer and tissue developmentSemantic proximity Read ↗

Emerging roles of DYRK2 in cancerSemantic proximity Read ↗

DYRK1A Kinase Inhibitors with Emphasis on CancerSemantic proximity Read ↗

Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.Semantic proximity Read ↗

DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cellsSemantic proximity Read ↗

A safe haven for cancer cells: tumor plus stroma control by DYRK1BSemantic proximity Read ↗

SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7Semantic proximity Read ↗

Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-MycSemantic proximity Read ↗

Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.